logo
Life expectancy for Californians still lower than before COVID — here's why

Life expectancy for Californians still lower than before COVID — here's why

Life expectancy for Californians has yet to rebound to pre-pandemic levels, and is still nearly one year shorter than it was before COVID-19, new research shows.
In 2024, life expectancy for Californians was 80.54 years — 0.86 years less than the 81.4 it was in 2019, according to the study, published Wednesday in JAMA.
Prior to the start of the pandemic, life expectancy in the state had been rising steadily; it fell sharply in 2020 (to 79.3) and 2021 (to 78.48) before rising again in 2022 (79.56) and 2023 (80.28).
But the 2024 data suggest that this progress is flatlining — a sign that COVID continues to have lingering effects on population-level health, despite the fact that it is no longer top of mind for most people.
'The reason why that's important is that the pandemic is still having effects on our health, even though everyone may have mentally moved on and wants to forget about it,' said study co-author Janet Currie, a professor of economics at Yale. 'It's still with us.'
The analysis, led by researchers at Yale, Northwestern, UCLA and Virginia Commonwealth University, used preliminary California data for 2024. National life expectancy data for 2024 is not yet available.
In California, 2024 marked the first time since the pandemic began that drug overdoses and cardiovascular disease both accounted for a greater share of the life expectancy decline than COVID. Drug overdoses accounted for 20% of the overall life expectancy decline, cardiovascular disease accounted for 16%, and COVID accounted for 13%.
That is the largest proportion of decline attributed to cardiovascular disease in several years.
The rise in cardiovascular-related deaths, which include deaths from heart attacks and stroke, is 'puzzling,' Currie said.
Some of it could be due to people not seeking health care during the early stretches of the pandemic, such as those who avoided the hospital even when they were having a heart attack or stroke, for fear of the virus. It may also be linked to rising obesity rates or long COVID, the latter of which can lead to inflammation and can be associated with higher rates of heart disease.
Drug overdoses skyrocketed during the pandemic but declined between 2023 and 2024 — accounting for 36% and 20% of the life expectancy drop, respectively.
'That's a piece of good news,' Currie said.
COVID has accounted for less and less of the life expectancy drop over time. In 2021, it accounted for 62% of the deficit. That fell to 36% in 2022, 16% in 2023 and 13% in 2024, the study found.
Out of all racial and ethnic groups, Hispanic residents experienced the biggest drop in life expectancy during COVID — more than five years, from 82.55 in 2019 to 77.37 in 2021 — but also rebounded relatively quickly in 2022 and 2023.
Asian residents continue to have the highest life expectancy — 85.51 years in 2024, compared to 81.11 for Hispanic residents, 79.94 for white residents and 73.42 for Black residents.
Economists study life expectancy because how long people expect to live impacts how much they need to save for retirement. And federal programs like Social Security and Medicare must factor in life expectancy when estimating costs.
Life expectancy in the U.S. improved significantly over the 20th century, Currie noted. Those gains happened in spurts thanks to advances like clean water, the development of antibiotics, major innovations in treating heart disease and cancer, and improvements in preventing infant mortality.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Are Americans Toking Themselves Sick?
Are Americans Toking Themselves Sick?

Medscape

time8 hours ago

  • Medscape

Are Americans Toking Themselves Sick?

This transcript has been edited for clarity. Welcome to Impact Factor , your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yale School of Medicine. Whenever you see a headline that says something is 'on the rise,' there are basically two possibilities. One, the thing is actually on the rise — like pickleball. The other possibility is that we're capturing the information differently nowadays. Either we are getting better at measuring something that has always been common (autism spectrum disorder may fall in this category, at least for part of the observed increase) or we are measuring something worse with more false positives driving up the observed rate, like UFO sightings. Ubiquitous phone cameras mean every little bit of swamp gas from a weather balloon trapped in a thermal pocket and reflecting the light from Venus gets recorded. It's the job of epidemiologists to figure out what is driving observed changes in our health, and this week I want to share some data that show that the rate of a specific cannabis-associated problem is not just on the rise; it is absolutely skyrocketing. Let's see if we can figure out why. I'm talking about cannabis hyperemesis syndrome (CHS), a once-rare condition characterized by cyclic episodes of what can be intractable vomiting. The exact physiology of CHS is still being worked out, but it probably has something to do with chronic exposure downregulating cannabinoid receptors in the gut, leading to decreased gut motility. Regardless of how exactly this works, the numbers suggest it is becoming dramatically more common — at least among adolescents, as highlighted in this research letter appearing in JAMA Network Open. Researchers interrogated the Pediatric Health Information System database which collates data from 52 free-standing children's hospitals around the United States. They were looking for adolescents admitted to the emergency department (ED) with diagnostic codes consistent with CHS, typically a chief complaint of nausea and vomiting, and at least a second diagnostic code indicating a 'cannabis-related concern.' These could be things like cannabis abuse or dependence. The time frame of interest was 2016 to 2023. Let's just take a look at the raw numbers. To give you some perspective, in 2006, there were 6.8 ED visits for CHS per 1 million population. In 2016, the start of this study, that number had jumped to 160.4, a more than 23-fold increase over a decade. These rates increased around 40% per year through 2023. The most recent data showed around 2000 visits for CHS per million population; that's a 30,000% increase in less than 20 years. Crazy numbers. But… are they real? Remember, when we see the rate of anything going up, we need to make sure we're not measuring it differently. And I certainly have some concern here that we are potentially unmasking a problem that has been there all along but not well documented until recently. Adolescents show up in the ED all the time for nausea and vomiting. The AHRQ publishes some of these data. For example, in 2018 there were nearly 800,000 visits for nausea and vomiting among those under age 18 — about 2.5% of all ED visits. The question is, how many of those had CHS? The study we're discussing this week would call it CHS if, in addition to the nausea and vomiting, they had a secondary code for a cannabis-related issue. I have no doubt that we use those codes more frequently now. For one thing, the broad-scale decriminalization and legalization of marijuana has removed much of the stigma that existed in the early 2000s. Doctors might be less worried about 'outing' these kids nowadays. Another possibility is that knowledge about CHS is spreading; with more marijuana use, doctors are getting more sensitive to the diagnosis. So perhaps some of those things we used to call a 'stomach bug' now get appropriately diagnosed as CHS. The converse could also be true. Since we're more comfortable adding cannabis-associated diagnosis codes now than we used to be in the past, we may currently be misclassifying people with nausea from another cause as CHS. Just because someone has cannabis use disorder or cannabis dependence doesn't mean they are not allowed to get norovirus. Of course, the other possibility is that there is a lot more marijuana use going on and with that, more CHS. The authors hypothesized that, if that were the case, we might see a more dramatic rise in states that have legalized recreational marijuana use. This is where the data get a bit weird. Because, yes, states with recreational marijuana legalization had more ED visits for CHS — overall, about 1900 cases per million vs 800 cases per million. But the rate of growth of those visits was more dramatic in states without recreational marijuana legalization. The authors don't opine on what would cause this pattern of observations. That's probably wise since the data are relatively limited. But that has never stopped me before, so here is what I think is going on. I think a lot of this is real. I suspect there is a true increase in the amount of CHS that is commensurate with the broader availability of marijuana in the marketplace. This leads to higher rates in states that have legalized recreational marijuana use. But a significant proportion of the observed increase is due to uncovering CHS in people who would not have received the diagnosis in the past and misclassification of non-CHS syndromes in the setting of people who happen to use marijuana. This occurs in states without legalized marijuana because, let's face it: Even in those states, the stigma about marijuana use is nowhere near what it was 10 or 20 years ago. The times they are a-changin', as one former pothead noted. Is this all a problem? CHS can be bad. In fact, just under half of the kids in this study required a hospital admission; a bit under 1% required the intensive care unit. That said, we should still contextualize these ED visits in the context of other risks adolescents face. I pulled a bit of data comparing ED visits for CHS to those for depression, suicide, gun violence, and drug overdoses. You can see here that CHS rates aren't as high as, say, ED visits for suicidal behavior, but these are all in the same ballpark. Of course, that's assuming the numbers in this study are not inflated. Still, it seems like we can add CHS to the list of real risks adolescents face in the United States today. And, if growth rates of the syndrome continue as they did in this study, rising by 50% per year, well, we can assume that every American adolescent will be in the ER for CHS by 2040. That would be… unlikely. But I suppose we can keep a bloodshot eye on it.

CDC says COVID-19 cases rising in 25 states
CDC says COVID-19 cases rising in 25 states

UPI

time10 hours ago

  • UPI

CDC says COVID-19 cases rising in 25 states

The U.S. Centers for Disease Control and Prevention estimates that 25 states are seeing growth in COVID cases as a summer wave appears to be starting, Adobe stock/HealthDay July 14 (UPI) -- COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast and West Coast. The U.S. Centers for Disease Control and Prevention estimates that 25 states are seeing growth in COVID cases as a summer wave appears to be starting, CBS News reported. Even though activity remains "low" nationwide - based on CDC wastewater data - it's up from "very low" the week before. Some of the biggest increases in emergency room visits for COVID have happened in the Pacific Northwest and the Southeast. In those areas, rates are now the highest they've been since February and March, CBS News added. Health experts had been watching for a possible summer spike, as new versions of the virus spread across the country. A recent CDC analysis shows that COVID now seems to follow a twice-a-year pattern: Cases usually peak once in the summer (July through September) and again in the winter (from December through February). "Our analysis revealed biannual COVID-19 peaks in late summer and winter, a pattern that is expected to persist as long as the rapid evolution of SARS-CoV-2 and cyclical S1 diversity continues," CDC scientists wrote. S1 diversity refers to ongoing changes in a key part of the virus's spike protein - specifically the S1 region, which helps the virus bind to human cells, CBS News reported. The CDC is also warning about another virus that's spreading more than usual right now: Parvovirus B19. Most people who catch this virus don't get very sick. But some develop flu-like symptoms, including fever, muscle aches and a rash. Pregnant women are at higher risk for complications from parvovirus B19. The CDC says they should take extra steps to protect themselves such as wearing a mask in high-risk places. In Chicago, health officials said emergency rooms are seeing a spike in patients with this virus. "Several of the most recent weeks saw the highest percentage of B19-associated ED visits compared to the same week in all years since 2015," health officials said. Parvovirus B19 is not the same parvovirus that infects dogs and other canines. More information The U.S. Centers for Disease Control and Prevention has more on parvovirus B19. Copyright © 2025 HealthDay. All rights reserved.

Solving the Healthcare Staffing Crisis: Why the Right Nurse Staffing Agency Matters More Than Ever
Solving the Healthcare Staffing Crisis: Why the Right Nurse Staffing Agency Matters More Than Ever

Time Business News

time11 hours ago

  • Time Business News

Solving the Healthcare Staffing Crisis: Why the Right Nurse Staffing Agency Matters More Than Ever

In the face of rising healthcare demands, an aging population, and growing staff shortages, healthcare providers across Australia are experiencing a critical need: reliable, qualified nursing professionals. Whether you're running a nursing home, a residential care facility, or a private clinic, ensuring consistent care without staffing interruptions is essential for maintaining both safety and trust. This is where a trusted nurse staffing agency like Medic24Connect becomes indispensable—offering you on-demand access to trained nurses, support staff, and carers, backed by systems built for 24/7 coverage and compliance. Healthcare isn't like any other industry. Here, the cost of even a single missed shift or unqualified replacement can be felt immediately by both staff and residents. And in Australia's residential and aged care sectors, the challenges are particularly steep: Aging workforce : Many current healthcare workers are nearing retirement age. : Many current healthcare workers are nearing retirement age. Burnout and turnover : Nurses and carers often experience emotional and physical fatigue. : Nurses and carers often experience emotional and physical fatigue. Pandemic aftermath : COVID-19 exposed major gaps in workforce planning. : COVID-19 exposed major gaps in workforce planning. Complex needs of patients: Today's patients often need specialized and continuous care, which requires consistency in the staff delivering it. Staffing gaps don't just hurt operations—they impact the dignity and safety of those who rely on care every day. It's not just about filling a position—it's about finding the right person for it. From a compassionate demeanor to clinical knowledge and the ability to adapt quickly to new environments, the ideal healthcare professional brings more than just qualifications—they bring comfort, reliability, and empathy. And that's why working with an agency that prioritizes vetting, compliance, and cultural fit can significantly impact patient care outcomes. For healthcare providers managing last-minute absences, sudden patient spikes, or seasonal demand, flexibility is key. This is where temporary staffing agency come in. They provide: Rapid response coverage for same-day or weekend shifts. for same-day or weekend shifts. Short-term contracts without long onboarding periods. without long onboarding periods. Access to multi-skilled professionals (ENs, RNs, AINs, PCAs). (ENs, RNs, AINs, PCAs). Peace of mind knowing you're covered even when core staff are unavailable. Temporary staffing is particularly valuable in cases like flu outbreaks, maternity leaves, or when transitioning through accreditation or audits where maximum staff support is essential. While temporary staffing is useful in high-pressure moments, long-term care delivery requires continuity. For that, a permanent staffing agency is your best ally. Greater consistency in patient or resident care. in patient or resident care. Reduced training and onboarding costs . . Stronger relationships between staff and residents , improving morale and patient satisfaction. , improving morale and patient satisfaction. Improved employee retention rates when matched properly. The right agency will not only help you fill vacancies but also assist in strategic workforce planning—anticipating your future staffing needs and building a talent pipeline accordingly. Not all staffing agencies are created equal. The best ones offer more than just a database of available workers—they offer a partnership. Look for the following attributes when choosing your nurse staffing provider: Ensure the agency complies with all local, state, and federal healthcare regulations and provides staff that are thoroughly background checked, vaccinated, and trained. Choose an agency with deep experience in residential care, aged care, disability care, and home health care, not just general staffing. Crisis doesn't keep office hours. Your staffing partner should be reachable and responsive at all times. Agencies that learn about your facility's unique culture and care model are more likely to provide staff who integrate smoothly with your existing team. Avoid hidden fees and long-term lock-ins. A trustworthy partner will offer flexibility and fair rates without compromising on quality. In residential care settings, the impact of staff on residents cannot be overstated. Familiarity, patience, and professional skill all lead to: Faster recovery times Lower readmission rates Improved emotional wellbeing Stronger trust with family members of residents Great staffing isn't just about operations—it's about lives. It's about providing care that feels personal, dignified, and consistent. Whether you need: A nurse for a 6-week contract, A last-minute PCA due to an emergency, Or a permanent staff member for dementia care, A specialized agency like Medic24Connect ensures you get the right fit—not just a warm body to fill a shift. They also support: Multilingual staff for multicultural communities. for multicultural communities. Shift planning support and compliance assistance. and compliance assistance. Ongoing training and upskilling to ensure staff stay updated with the latest in care standards. True peace of mind in healthcare staffing comes from more than just filling gaps—it comes from a relationship built on trust, communication, and consistency. Medic24Connect believes in this approach and offers customized staffing strategies aligned with your values and operational needs. Whether you require short-term relief or permanent placements, their team works with you to anticipate, fulfill, and exceed your staffing goals—allowing your facility to focus on what matters most: quality care. From aged care homes to disability support providers, the need for qualified, compassionate staff has never been more urgent. Navigating this demand requires more than reactive hiring—it demands a proactive partnership with a proven nurse staffing agency that understands your specific challenges. With services tailored across both medical temporary staffing agencies and permanent staffing agency solutions, Medic24Connect ensures you're never left short-handed—no matter the situation. Let your staff shortages be a thing of the past. Let Medic24Connect be your trusted healthcare staffing partner. TIME BUSINESS NEWS

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store